nRichDX at the AMP 2024 Annual Meeting
nRichDX exhibited and presented at the Association for Molecular Pathology Annual Meeting 2024 in Vancouver, showcasing liquid biopsy sample preparation solutions and collaborative research.
Liquid Biopsy Sample Preparation at the AMP Annual Meeting
nRichDX presented new data and exhibited at the Association for Molecular Pathology (AMP) Annual Meeting 2024. The meeting was held November 19-23 at the Vancouver Convention Centre in Vancouver, British Columbia, Canada.
nRichDX exhibited in booth #1321. Exhibits opened at 11:15 AM on Thursday, November 21 and closed at 1:30 PM on Saturday, November 23.
AMP attendees working in liquid biopsy and the extraction of analytes including ctDNA, ctRNA, cell-free total nucleic acid (cfTNA), and the enrichment of circulating tumor cells (CTCs) were invited to visit the nRichDX booth to learn more about liquid biopsy sample preparation solutions.
What nRichDX Highlighted at AMP 2024
Sample preparation capabilities, analyte recovery, and collaborative research across liquid biopsy applications.
Liquid Biopsy Analytes
Sample preparation solutions supporting circulating nucleic acids and circulating tumor cell applications.
Expanded Sample Volumes
The Revolution platform was described at the time as supporting sample volumes from as little as 1 mL to 100 mL in a single extraction.
Collaborative Research
At least three scientific posters at AMP 2024 included nRichDX sample preparation solutions.
Assay Performance
nRichDX highlighted the relationship between analyte recovery, molecular input, assay sensitivity, and earlier detection of targeted oncology markers.
Three Collaborative Posters Featuring nRichDX Solutions
Collaborative Liquid Biopsy Research
At least three posters planned for the AMP 2024 meeting incorporated nRichDX sample preparation solutions.
Enhanced Extraction and Preservation of Circulating Cell-Free RNA from 50 mL Cell-Free Urine
Presented in collaboration with Agilent Technologies.
The Mutational Landscape of Circulating Tumor Cells in Pancreatic Cancer
Presented in collaboration with Dartmouth Hitchcock Medical Center.
Clinical Validation of Cell-free DNA (cfDNA) Extraction from Whole Blood Plasma using the nRichDX® Revolution Max 20 Kit and Sample Prep System
Presented in collaboration with Dartmouth Hitchcock Medical Center.
Explore the Research Library
Access nRichDX posters, publications, application notes, webinars, and additional liquid biopsy resources.
Sample Preparation Across Liquid Biopsy Applications
At the time of AMP 2024, nRichDX described the patented Revolution Sample Prep System™ as engineered specifically for liquid biopsy applications and the isolation of analytes from blood, plasma, urine, and other biofluids.
The platform was described as processing sample volumes from as little as 1 mL to 100 mL in a single extraction using Revolution nRicher™ Cartridges.
Sample input capability described in nRichDX's AMP 2024 event materials.
- Blood
- Plasma
- Urine
- Other Biofluids
AMP 2024 has concluded.
Explore current nRichDX news, events, products, and liquid biopsy sample preparation resources.